Who is sponsoring NCT06011473?

NCT06011473 is sponsored by Medical University of Gdansk.

What drugs are being tested in NCT06011473?

Interventions in NCT06011473: CGM (FreeStyle Libre 3).

What condition does NCT06011473 study?

NCT06011473 studies Continuous Glucose Monitoring, Colorectal Cancer.

Is NCT06011473 still recruiting?

NCT06011473 is currently status unknown. Last updated 31 August 2023.

Last reviewed 2023-08-31 · How we verify

NCT06011473: CGM-CRC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Glucose Monitoring for Colorectal Cancer

Status unknown NA Last updated 31 August 2023

What this trial tests

NA trial testing CGM (FreeStyle Libre 3) in Continuous Glucose Monitoring in 40 participants. Status unknown.

Timeline

27 August 2023

Primary endpoint
31 August 2024

31 August 2024

Quick facts

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	27 August 2023
Primary completion	31 August 2024
Estimated completion	31 August 2024
Sites	1 location across Poland

Drugs / interventions tested

CGM (FreeStyle Libre 3)

Conditions studied

Continuous Glucose Monitoring — all drugs for Continuous Glucose Monitoring →
Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Continuous Glucose Monitoring or Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hyperglycemia commonly occurs during surgery due to a reaction to metabolic stress and trauma. It has been shown that improper glycemia control leads to impaired wound healing and a higher risk of other postoperative complications. The primary aim of our project is to assess the feasibility of the use of continuous glucose monitoring in measuring blood glucose levels in patients undergoing colorectal cancer surgery. The secondary aim is to analyze changes in perioperative blood glucose levels to understand the effects of stress and intraoperative interventions on the blood glucose level. The tertiary goal is to assess the predictive value of hyperglycemia for surgical site infection.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches.
Zhou R, Wang F, Wen J, Zhou X, et al · · 2025 · cited 2× · PMID 40884151 · DOI 10.1002/cam4.71185
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes.
Ajjan RA, Seidu S, Riveline JP. · · 2024 · cited 2× · PMID 38907936 · DOI 10.1007/s13300-024-01607-5

Verify or expand the search:

Other recruiting trials for Continuous Glucose Monitoring

Currently open trials in the same condition.

NCT07097415 — The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes · NA · recruiting
NCT06648174 — The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus · NA · recruiting
NCT06641765 — Continuous Glucose Monitoring in Dialysis Patients With Diabetes · NA · active not recruiting
NCT06716671 — Influence of Continuous Glucose Monitoring on Quality of Life in People With Type 2 Diabetes Mellitus · active not recruiting
NCT06436326 — The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes · NA · recruiting

Other Medical University of Gdansk trials

Trials by the same sponsor.

NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06011473 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
Last refreshed: 31 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing